Evaluation of RAD001 as Therapy for Patients With Systemic Mastocytosis.

Trial Profile

Evaluation of RAD001 as Therapy for Patients With Systemic Mastocytosis.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Aug 2012

At a glance

  • Drugs Everolimus (Primary)
  • Indications Systemic mastocytosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 May 2009 Planned end date changed from 1 Apr 2009 to 1 Apr 2010 as reported by ClinicalTrials.gov.
    • 12 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top